Abstract
Expression of CD20, evaluated as antibody binding capacity (ABC) (i.e. absolute number of molecules of antibody per cell), was analyzed using flow cytometry on leukemic cells of 93 previously untreated patients, all fulfilling strict criteria of "immunologically typical" (i.e. CD5+, CD23+) B-cell chronic lymphocytic leukemia (CLL). Although changes of CD20 antigen density did not correlate with clinical parameters representative of either tumor mass (i.e. clinical stage, histological pattern of bone marrow involvement, absolute peripheral blood lymphocytosis) or disease progression (i.e. lymphocyte doubling time), a trend toward a better life-expectancy was observed in the low CD20 expression group compared with the high CD20 expression group (p = 0.05; relative risk of death, 0.51, 95% confidence interval, 0.24-1.04). Given the correlation between CD20 ABC and mean fluorescence intensity (MFI) of light chain (LC) surface immunoglobulins (Sm Ig) (r = 0.481, p < 0.0001), as well as the impact of MFI of Sm Ig LC on overall survival (p = 0.01; relative risk of death 0.44; 95% confidence interval, 0.10 to 0.76), we tried to verify whether a combination of B-cell markers, evaluated in a quantitative manner, could have additive progn...Continue Reading
References
Jan 1, 1977·British Journal of Cancer·R PetoP G Smith
Aug 1, 1992·American Journal of Hematology·N M AlmasriR C Braylan
May 1, 1992·British Journal of Haematology·A S KurecF R Davey
Jan 1, 1991·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·C D DawsonR C Holman
May 1, 1989·American Journal of Hematology·A OrfaoA Lopez Borrasca
Jun 1, 1989·Journal of Clinical Pathology·J M BennettC Sultan
Jul 1, 1989·American Journal of Clinical Pathology·A TefferiR L Phyliky
Feb 1, 1989·Annals of Internal Medicine
Dec 17, 1985·Journal of Immunological Methods·P Poncelet, P Carayon
Mar 1, 1986·British Journal of Haematology·E MontserratC Rozman
Jul 1, 1981·Cancer·J L BinetF Gremy
Jan 1, 1997·Current Opinion in Oncology·E Montserrat
Jan 1, 1991·Leukemia & Lymphoma·E LegacH Merle-Beral
Citations
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M ForanT A Lister
Jul 27, 2000·American Journal of Hematology·G D'ArenaM Carotenuto
Nov 24, 2001·Blood·J GolayM Introna
Nov 9, 2001·Leukemia & Lymphoma·G D'ArenaM Carotenuto
Jun 15, 2007·Cytometry. Part B, Clinical Cytometry·Eva D RossmannAnders Osterborg
Aug 1, 2020·The Cochrane Database of Systematic Reviews·Nina KreuzbergerNicole Skoetz
Jan 23, 1999·Current Opinion in Hematology·P M LydyardP Y Youinou
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Angela D Hamblin, Terry J Hamblin
May 1, 2007·Expert Review of Clinical Immunology·Amani MankaiPierre Youinou
Nov 9, 2001·Leukemia & Lymphoma·B GuJ Wiley
Nov 8, 2001·Leukemia & Lymphoma·G D'ArenaM M Greco
Nov 17, 2001·American Journal of Clinical Pathology·J L FraterE D Hsi
Nov 26, 2008·Blood·Nathalie A JohnsonRandy D Gascoyne
Mar 15, 2006·Immunological Investigations·Scott H OlejniczakMyron S Czuczman